Contact leukoderma caused by buspirone patches.
Chapman
M Shane
MS
Perazd
José E
JE
Perry
Ann E
AE
Zug
Kathryn A
KA
Brown
Charles I
CI
D000279:Administration, Cutaneous; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001007:Anxiety / Q000188:drug therapy; D001132:Arm; D002065:Buspirone / Q000008:administration & dosage / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D003937:Diagnosis, Differential; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D008875:Middle Aged
D014151:Anti-Anxiety Agents; D002065:Buspirone